Genetic variation of 3β-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: Implications for prostate cancer risk
- 15 September 1997
- journal article
- Published by Wiley in The Prostate
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Evidence of an X-linked or recessive genetic component to prostate cancer riskNature Medicine, 1995
- Progress in prostate cancerNature Genetics, 1995
- The prognosis for prostate cancerNature Genetics, 1994
- Dinucleotide repeat polymorphisms in the HSD3B2 geneHuman Molecular Genetics, 1994
- Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissuesThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Congenital adrenal hyperplasia due to point mutations in the type II 3β–hydroxysteroid dehydrogenase geneNature Genetics, 1992
- 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black malesThe Lancet, 1992
- Assignment of the human 3β-hydroxysteroid dehydrogenase gene (HSDB3) to the p13 band of chromosome 1Cytogenetic and Genome Research, 1989